Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
X4 Pharmaceuticals Inc banner

X4 Pharmaceuticals Inc
NASDAQ:XFOR

Watchlist Manager
X4 Pharmaceuticals Inc Logo
X4 Pharmaceuticals Inc
NASDAQ:XFOR
Watchlist
Price: 3.71 USD 1.37% Market Closed
Market Cap: $324.4m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

XFOR Price Targets Summary
X4 Pharmaceuticals Inc

Wall Street analysts forecast XFOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XFOR is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 13.65 USD.

XFOR Lowest Forecast
Wall Street Target
4.04 USD
9% Upside
XFOR Average Forecast
Wall Street Target
8.16 USD
120% Upside
XFOR Highest Forecast
Wall Street Target
13.65 USD
268% Upside
Lowest
Price Target
4.04 USD
9% Upside
Average
Price Target
8.16 USD
120% Upside
Highest
Price Target
13.65 USD
268% Upside
X4 Pharmaceuticals Inc Competitors:
Price Targets
B
0HQ1
Brooks Automation Inc
7% Upside
IDXX
IDEXX Laboratories Inc
21% Upside
B
0HQ1
Brooks Automation Inc
7% Upside
IDXX
IDEXX Laboratories Inc
21% Upside

Revenue
Forecast

N/A
Past Growth
160% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
160% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of X4 Pharmaceuticals Inc's revenue for the next 4 years is 160%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss

What are analyst estimates?

See Also

Summary
XFOR intrinsic value, competitors valuation, and company profile.
DCF Valuation
XFOR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XFOR stock valuation using valuation multiples.
Wall Street Estimates
XFOR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XFOR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XFOR's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for XFOR is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 13.65 USD.

What is X4 Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
160%

The compound annual growth rate of X4 Pharmaceuticals Inc's revenue for the next 4 years is 160%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.